Has Stanford Taylor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,900 in general payments to Stanford Taylor, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanford Taylor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanford Taylor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanford Taylor, MD

Retina Specialist · Colorado Springs, CONPI 1013250240

Payments from drug & device makers

What this record shows

This record is dominated by other: $3,326 of the $4,900 with a category attached, or 67.9%. US Retina LLC accounts for 86.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $3,326 and has fallen 99.5% since, to $18 in 2024.

$4,900in general payments, 2019–2025

Across 18 payments — averaging $272.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

US Retina LLC$4K
Alimera Sciences, Inc.$255
Genentech USA, Inc.$130
Alcon$57
Apellis Pharmaceuticals, Inc.$44
Genentech, Inc.$40
plus $118 from 5 others

$873,852in research payments, 2019–2025

Across 39 payments — averaging $22,406 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$804K
Eyepoint US, Inc.$70K

What the payments were for

Food & beverage$62713%
Entertainment$160%
Ownership interest$93119%
Other$3,32668%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
US Retina LLC	2	$4,257
Alimera Sciences, Inc.	2	$255
Genentech USA, Inc.	2	$130
Alcon	1	$57
Apellis Pharmaceuticals, Inc.	1	$44
Genentech, Inc.	2	$40
AbbVie(2 entities)	2	$32
Regeneron Healthcare Solutions, Inc.	2	$30
Eyepoint US, Inc.	1	$24
Novartis	1	$16
Optos, Inc.	2	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Iluvien$255
Lucentis$114

How this compares

$4,900 in reported general payments places this provider in the 55th percentile of 51 retina specialist providers in Colorado.

See all retina specialist providers in Colorado →

Medicare billing

Part B allowed, 2024

$3,661,048

Medicare patients

879

Services billed

34,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	210	$7,252
Ciprofloxacin Hcl	142	$1,668
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	46	$696
Dorzolamide Hcl	20	$282
Latanoprost	27	$202
Timolol Maleate	16	$163
Brimonidine Tartrate	20	$151

Paid to pharmacies, not to this prescriber.

Other retina specialist in Colorado Springs

Adam MartidisColorado Springs$15K
James LuuColorado Springs$11K
Cecinio RonquilloColorado Springs$10K
Ramin SarrafizadehColorado Springs$6K
Mark ChittumColorado Springs$4K
Amar ManninaColorado Springs$2K
Jonathan WilliamsColorado Springs$367
Murtaza AdamParker$548K
Alan KimuraDenver$546K
Brian JoondephDenver$92K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →